This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: Dejan Mandic: Innovator in Pharmaceutical Chemistry
Introduction
Dejan Mandic is a prominent inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes related to esomeprazole sodium and omeprazole salts. With a total of 4 patents to his name, Mandic continues to push the boundaries of innovation in his field.
Latest Patents
Mandic's latest patents include a process for the preparation of esomeprazole sodium of high chemical purity. This innovative process involves providing a solution of esomeprazole sodium in a solvent primarily composed of methanol, followed by precipitation or crystallization. The method ensures that esomeprazole sodium is obtained in a pure form through chiral chromatography and a subsequent reaction with a sodium source. Additionally, he has developed a process for solvent removal from omeprazole salts, specifically focusing on magnesium salts. This invention enhances the efficiency of pharmaceutical compositions containing omeprazole.
Career Highlights
Dejan Mandic is associated with Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. His work at Lek has allowed him to contribute to the advancement of pharmaceutical technologies and improve the quality of medications available to patients. His expertise in chemical processes has been instrumental in the development of new pharmaceutical formulations.
Collaborations
Mandic has collaborated with notable colleagues, including Renata Toplak Casar and Lidija Vranicar Savanovic. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical sector.
Conclusion
Dejan Mandic is a key figure in pharmaceutical innovation, with a focus on improving the purity and efficiency of important medications. His contributions through patents and collaborations highlight his commitment to advancing the field of pharmaceutical chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile